CNB-001

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NameCNB-001
Drug Alias Namecurcumin derivative (Salk Institute)CNB-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsAlzheimer DiseaseStrokeBrain Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSalk Institute for Biological Studies
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSalk Institute for Biological Studies
Active IndicationsN/A
Inactive IndicationsAlzheimer DiseaseStrokeBrain Injuries

Other Information

ATC CodeN/A
Related LinksN/A